CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL

NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF

GPR40 AGONISTS

IDURONIDASE STABILIZERS AND USES THEREOF

COMPOUND AS KIF18A INHIBITOR

PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS

METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS

METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES

SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES

LUMINALLY-ACTING N-(PIPERIDIN-4-YL)BENZAMIDE DERIVATIVES

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL

BIARYL DIALKYL PHOSPHINE OXIDE FPR2 AGONISTS

GPR40 agonists

INHIBITORS OF THE ENZYME ENOLASE FOR PRECISION ONCOLOGY

Process for preparing sulfonamide compounds

PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex

ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS

OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS

Antiproliferative compounds, and their pharmaceutical compositions and uses

Prodrugs of pyridone amides useful as modulators of sodium channels

Polymerizable compounds with one or more surfactant-like properties

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Solid supports and phosphoramidite building blocks for oligonucleotide conjugates

Soluble C5aR antagonists

Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands

Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

Sulfur derivatives as chemokine receptor modulators

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

Kinase inhibitors

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Prodrugs of pyridone amides useful as modulators of sodium channels

Soluble C5aR antagonists

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Non-halogenated flame retardant hindered amine light stabilizer cross-linkers

Antiproliferative compounds, and their pharmaceutical compositions and uses

Methylphenidate-Prodrugs, Processes of Making and Using the Same

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Prodrugs of phenolic TRPV1 agonists

Soluble C5aR antagonists

Oligonucleotide compositions and methods thereof

Kinase inhibitors

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

Hydrophilic fentanyl derivatives

Antiproliferative compounds, and their pharmaceutical compositions and uses

Enolase inhibitors and methods of treatment therewith

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds

Prodrugs of pyridone amides useful as modulators of sodium channels

Solid supports and phosphoramidite building blocks for oligonucleotide conjugates

Anthracene-9, 10-dione dioxime compound prodrugs and their uses

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Methylphenidate-prodrugs, processes of making and using the same

Sulfur derivatives as chemokine receptor modulators

RADICAL ORBITAL SWITCHING

Alkylated imino sugars exhibiting glucosidase inhibition and their method of use

()-3-((3,4)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disorders

Method of treatment with prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin in-2-1H-one and derivatives thereof

Fluorine-containing phosphate ester-amide, and flame retardant resin, flame retardant liquid and flame retardant solvent for organic synthesis containing same

Aminophosphinic derivatives that can be used in the treatment of pain

MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS

N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS

PHOSPHO-SUBSTITUTED ALKOXYAMINE COMPOUNDS

Nitroso compounds as nitroxyl donors and methods of use thereof

Phosphonic acid compounds as inhibitors of serine proteases

PROCESS FOR SYNTHESIZING PHOSPHONIC AND PHOSPHINIC ACID COMPOUNDS

Method for the manufacture of aminohydroxy diphosphonic acids

Phosphonic acid compounds as inhibitors of serine proteases

Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol

Sulfur derivatives as chemokine receptor modulators

Phosphorous derivatives as chemokine receptor modulators

Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1H)-one and derivatives thereof

Polymer nanoparticles

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Chemical compounds

Potent non-urea inhibitors of soluble epoxide hydrolase

Phosphonic acid compounds as inhibitors of serine proteases

Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference

Metal complex and method for producing α-olefin polymer and method for producing α-olefin/(meth)acrylate copolymer using the same

Macrocyclic Prodrug Compounds Useful as Therapeutics

Method for producing organic compound and organic compound obtained by the method

Aminophosphinic derivatives that can be used in the treatment of pain

Phosphonic acid compounds as inhibitors of serine proteases

Phosphonium salts derivatives and uses thereof

Phosphonic acid compounds as inhibitors of serine proteases

Phosphonic acid compounds as inhibitors of serine proteases

Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity

Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers

Substituted piperidine compounds and methods of their use

COMPOSITIONS AND METHODS FOR TREATING BONE CANCER

Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol

Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases

Biocompatible polymeric compound, biocompatible polymer and polymer particles

Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines

Nitroso compounds as nitroxyl donors and methods of use thereof

Electrostatic-image-developing toner, method of producing the same, electrostatic image developer, image forming method and image forming apparatus

In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging

Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex

Phosphonic acid compounds as inhibitors of serine proteases

Novel phosphonic acid compounds as inhibitors of serine proteases

Novel phosphonic acid compounds as inhibitors of serine proteases

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF

Phosphonic acid compounds as inhibitors of serine proteases

Process for synthesizing phosphonic and phosphinic acid compounds

Novel phosphonic acid compounds as inhibitors of serine proteases

Phosphonic acid compounds as inhibitors of serine proteases

Novel phosphonic acid compounds as inhibitors of serine proteases

Phosphonic acid compounds as inhibitors of serine proteases

Novel phosphonic acid compounds as inhibitors of serine proteases

Charge tags and the separation of nucleic acid molecules

Therapeutic substituted piperidone compounds

Novel inhibitors of chymase

Cycloolefin phosphine ligands and their use in catalysis

Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease

Phosphagen synthesis

Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof

Sulfonyl amino cyclic derivatives and use thereof

Electrochromic compound

Protein tyrosine phosphatase inhibitors and methods of use thereof

Inhibitors of glutaminyl cyclase

Process for the controlled increase in the molecular weight of polyethylenes

2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates

Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia

Novel Sulfonamide derivative

Process for Making Substituted Piperidines

Sulfonylethyl phosphorodiamidates

Ionic UV-A sunscreens and compositions containing them

Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives

Phosphonium salts derivatives

Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases

Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives

Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex

T-type calcium channel blocker

5-thiopiperdinyl prostaglandin E analogs

Fluorine-containing polymer, resist composition prepared from same and novel fluorine-containing monomer

Phosphazenium salt mixtures containing hexakis(amino)diphosphazenium, tetrakis(amino)-phosphonium and polyaminophosphazenium salts

1,1-and 1,2-Bisphosphonates as apoliprotein e modulators

Novel fluorine-containing polymer, resist composition prepared from same and novel fluorine-containing monomer

Compositions comprising oxophosphonate-based metalloproteinase inhibitors

Lipophilic compounds and uses thereof

Protein tyrosine phosphatase inhibitors and methods of use thereof

Trisubstituted nitrogen modulators of tyrosine phosphatases

Flame retarding compounds

Process for the controlled increase in the molecular weight of polyethylenes

Antineoplastic ether lipid compounds with modifications at the sn-2 carbon

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

Antiprotozoal ring-substituted phospholipids

Substituted piperidine compounds and methods of their use

Carboxamide derivatives and their use as factor Xa inhibitors

Noncardiotoxic pharmaceutical compounds

Process for the preparation of Fexofenadine

Sulfonylethyl phosphorodiamidates

Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1)

Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays

Alpha-substituted beta-aminoethyl phosphonate derivatives

Inhibitors of chymase

Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same

α-Amino-N-(diaminophosphinyl)lactam derivatives

Charge tags and the separation of nucleic acid molecules

Nanoporous and nanocrystalline film and electrochromic device

Electrochromic compound

Il-6 production inhibitors

Phosphorous organic compounds and their use

Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease

Process for reacting alkaloids and use of the reaction products in the preparation of medicaments

N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists

Method for preparing sulphostin and analogue thereof or preparation intermediate thereof